Literature DB >> 1458688

Gene frequency and partial protein characterization of an allelic variant of mannan binding protein associated with low serum concentrations.

P Garred1, S Thiel, H O Madsen, L P Ryder, J C Jensenius, A Svejgaard.   

Abstract

Low plasma concentration of mannan binding protein (MBP) has been shown to be the basis for a common opsonic deficiency and suggested to be caused by a single nucleotide substitution at base 230 of exon 1 in the MBP gene. This substitution causes a replacement of glycine (codon GGC) with aspartic acid (codon GAC). Of 123 healthy Danish individuals investigated by polymerase chain reaction performed on exon 1, followed by restriction fragment length polymorphism or allospecific probing, 93 were homozygous (75.6%) for GGC, 28 heterozygous (22.8%), and two homozygous for GAC (1.6%). The gene frequency of the GAC allele was found to be 0.13. DNA sequencing of the cloned exon 1 from one GAC homozygous individual revealed no other substitution. The median MBP concentration in the group containing the GAC allele was 6.4 times lower than in the GGC homozygous group (195 and 1234 micrograms/l respectively). However, the range in plasma concentrations of MBP was wide and overlapping between the groups. MBP protein was detected in both the GAC homozygotes (9 and 387 micrograms/l). Furthermore, no difference in relative mass and biological activity (mannan binding) was found when sera containing the two forms of MBP were investigated. Accordingly, it can be concluded that the GAC allele is able to produce a functional MBP protein which may be detected in serum at low concentrations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1458688      PMCID: PMC1554582          DOI: 10.1111/j.1365-2249.1992.tb05876.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

Review 1.  Complement deficiency and disease.

Authors:  B P Morgan; M J Walport
Journal:  Immunol Today       Date:  1991-09

2.  Deficiency of mannan binding protein--a new complement deficiency syndrome.

Authors:  M W Turner
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

Review 3.  Functions and relevance of the terminal complement sequence.

Authors:  S Bhakdi; F Hugo; J Tranum-Jensen
Journal:  Blut       Date:  1990-06

4.  Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme C1r2C1s2 complex, of the classical pathway of complement, without involvement of C1q.

Authors:  J H Lu; S Thiel; H Wiedemann; R Timpl; K B Reid
Journal:  J Immunol       Date:  1990-03-15       Impact factor: 5.422

Review 5.  Interleukin-1 and the pathogenesis of the acute-phase response.

Authors:  C A Dinarello
Journal:  N Engl J Med       Date:  1984-11-29       Impact factor: 91.245

6.  Molecular basis of opsonic defect in immunodeficient children.

Authors:  M Sumiya; M Super; P Tabona; R J Levinsky; T Arai; M W Turner; J A Summerfield
Journal:  Lancet       Date:  1991-06-29       Impact factor: 79.321

7.  Human class II major histocompatibility antigen beta-chains are derived from at least three loci.

Authors:  J Böhme; D Owerbach; M Denaro; A Lernmark; P A Peterson; L Rask
Journal:  Nature       Date:  1983-01-06       Impact factor: 49.962

8.  Serum lectin with known structure activates complement through the classical pathway.

Authors:  K Ikeda; T Sannoh; N Kawasaki; T Kawasaki; I Yamashina
Journal:  J Biol Chem       Date:  1987-06-05       Impact factor: 5.157

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins.

Authors:  R A Ezekowitz; L E Day; G A Herman
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  30 in total

1.  Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: mannan-binding proteindependent cell-mediated cytotoxicity.

Authors:  Y Ma; K Uemura; S Oka; Y Kozutsumi; N Kawasaki; T Kawasaki
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

Review 2.  Genetic heterogeneity of mannose-binding proteins: the Jekyll and Hyde of innate immunity?

Authors:  R A Ezekowitz
Journal:  Am J Hum Genet       Date:  1998-01       Impact factor: 11.025

3.  Total C4B deficiency due to gene deletion and gene conversion in a patient with severe infections.

Authors:  Taina Jaatinen; Meri Lahti; Olli Ruuskanen; Riikka Kinos; Lennart Truedsson; Riitta Lahesmaa; Marja-Liisa Lokki
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

4.  Chicken mannose-binding lectin (MBL) gene variants with influence on MBL serum concentrations.

Authors:  Rikke M Kjærup; Liselotte R Norup; Karsten Skjødt; Tina S Dalgaard; Helle R Juul-Madsen
Journal:  Immunogenetics       Date:  2013-03-02       Impact factor: 2.846

5.  DNase I hypersensitivity mapping and promoter polymorphism analysis of human C4.

Authors:  A K Vaishnaw; R Hargreaves; R D Campbell; B J Morley; M J Walport
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

6.  Mannose-binding lectin is a disease modifier in clinical malaria and may function as opsonin for Plasmodium falciparum-infected erythrocytes.

Authors:  Peter Garred; Morten A Nielsen; Jørgen A L Kurtzhals; Rajneesh Malhotra; Hans O Madsen; Bamenla Q Goka; Bartholomew D Akanmori; Robert B Sim; Lars Hviid
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

7.  Mannan-binding protein--levels in plasma and upper-airways secretions and frequency of genotypes in children with recurrence of otitis media.

Authors:  P Garred; K Brygge; C H Sørensen; H O Madsen; S Thiel; A Svejgaard
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

8.  A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein.

Authors:  H O Madsen; P Garred; J A Kurtzhals; L U Lamm; L P Ryder; S Thiel; A Svejgaard
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

9.  Binding of mannan-binding protein to various bacterial pathogens of meningitis.

Authors:  L C van Emmerik; E J Kuijper; C A Fijen; J Dankert; S Thiel
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

10.  MBL2 genetic polymorphisms and HIV-1 mother-to-child transmission in Zambia.

Authors:  Luisa Zupin; Vania Polesello; Ludovica Segat; Louise Kuhn; Sergio Crovella
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.